Woods Karen, Douketis James D, Kathirgamanathan Kala, Yi Qilong, Crowther Mark A
Department of Medicine, McMaster University and St. Joseph's Healthcare, Room F-544, 50 Charlton Ave. East, Hamilton, ON, Canada L8N 4A6.
J Thromb Thrombolysis. 2007 Oct;24(2):93-7. doi: 10.1007/s11239-007-0022-z. Epub 2007 Mar 23.
In patients who require warfarin interruption before surgery and have an elevated international normalized ratio (INR) before surgery, low-dose vitamin K may normalize the INR in time for surgery.
In a retrospective cohort study, we assessed the efficacy of 1 mg oral vitamin K to normalize the INR for surgery and whether resistance to re-anticoagulation occurs when warfarin is restarted after surgery. We studied a cohort of patients with an INR 1.4-1.9 on the day before surgery who received 1 mg oral vitamin K (vitamin K group), and a comparator group of patients with a normal INR (< or = 1.3) on the day before surgery who did not receive vitamin K (no vitamin K group). In both patient groups, we determined the proportion of patients with a normalized INR on the day of surgery and compared the mean INR after surgery when warfarin was resumed.
Of 43 patients in the vitamin K group, the INR was normalized (< or = 1.3) in 33 patients (76.6; 95% confidence interval [CI]: 64.1-89.4), and the INR was normal or near-normal (< or = 1.4) in 39 patients (90.7; 95% CI: 82.0-99.4) on the day of surgery. The mean (standard deviation) INR in the vitamin K and no vitamin K group 4-8 days after surgery was 1.75 (0.34) and 1.59 (0.36), respectively (P = 0.56).
In patients requiring interruption of warfarin for surgery, 1 mg oral vitamin K on the day before surgery can normalize the INR by the day of surgery and may not confer resistance to warfarin re-anticoagulation after surgery.
对于手术前需要停用华法林且术前国际标准化比值(INR)升高的患者,低剂量维生素K可能使INR及时恢复正常以便进行手术。
在一项回顾性队列研究中,我们评估了口服1毫克维生素K使INR恢复正常以便进行手术的疗效,以及术后重新开始使用华法林时是否会出现抗凝抵抗。我们研究了一组术前一天INR为1.4 - 1.9的患者,他们接受了口服1毫克维生素K(维生素K组),以及一个对照队列,即术前一天INR正常(≤1.3)且未接受维生素K的患者(无维生素K组)。在两组患者中,我们确定了手术当天INR恢复正常的患者比例,并比较了术后重新使用华法林时的平均INR。
维生素K组的43例患者中,33例患者(76.6%;95%置信区间[CI]:64.1 - 89.4)的INR恢复正常(≤1.3),39例患者(90.7%;95% CI:82.0 - 99.4)在手术当天INR正常或接近正常(≤1.4)。术后4 - 8天,维生素K组和无维生素K组的平均(标准差)INR分别为1.75(0.34)和1.59(0.36)(P = 0.56)。
对于因手术需要停用华法林的患者,术前一天口服1毫克维生素K可使手术当天INR恢复正常,且术后可能不会导致对华法林重新抗凝产生抵抗。